spacer
home > > summer 2009 > shipping standards
PUBLICATIONS


Shipping Standards

It is an exciting time for those with an interest in the pharmaceutical cold chain. While change often causes uncertainty, for those engaged in the heavily regulated healthcare industry, the ongoing refinement of guidance further clarifies the regulatory requirements for the storage and distribution of temperature sensitive products.

The FDA requirements for pharmaceutical products simply refer to “storage of drug products under appropriate conditions of temperature, humidity and light so that the identity, strength, quality and purity of the drug products are not affected” (1). The World Health Organization’s (WHO) Good Distribution Practices for Pharmaceutical Products notes that “where special storage conditions (such as particular temperatures) are required during transit, these should be provided, checked, monitored and recorded” (2).

While these requirements are defined in basic terms, it is left to the healthcare industry to develop the policies and procedures, and if necessary, to rationalise their methods to the regulatory authorities. The stakes are high, given that failure to comply could cause both the product and responsible person to be subject to regulatory (and possibly punitive) actions.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Chris Fore is the Technical Support Manager for Envirotainer, and has overall responsibility for the Qualified Envirotainer Provider Training and Quality Program. After graduating from the University of North Carolina, he started working in the field of quality management 15 years ago while living in Japan and Thailand. Since then, he has developed quality systems and conducted audits at supplier locations throughout Asia, the US and Europe. He participates in such industry groups as the Pharmaceutical Cold Chain Interest Group and International Air Transport Association (IATA).
spacer
Chris Fore
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine

Keele, UK and Matfors, Sweden, 30 March 2020: Cobra Biologics (Cobra), an international CDMO for biologics and pharmaceuticals, and the Karolinska Institutet (KI), one of the world’s leading medical universities, today announced they have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium to support global efforts tackling the pandemic. Partners in the consortium also include Karolinska University Hospital, Public Health Authority (FoHM), IGEA, Adlego AB and Giessen University.
More info >>

White Papers

Changing Structural Landscape for Comparator Drug Supply

ADAllen Pharma

TransCelerate Biopharma is focused on advancing innovation in R&D, identifying and solving common R&D challenges and further improving patient safety, with the goal of delivering more high quality medicines to patients. In 2013, they announced its Clinical Trial Comparator Network initiative to show a mutual commitment to offer secure and rapid supply of comparator drug products. The aim of this article is to unpack the section on 'Comparator Drugs' and analyse the rationale for attempting to achieve their objectives.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement